![](https://www.pymnts.com/wp-content/uploads/2020/06/shutterstock_299616500-e1585089084579-2.jpg)
Momenta Pharmaceuticals and Novartis AG unit Sandoz got final approval from a Tennessee federal judge for a $120 million settlement of claims that they tricked regulators into incorporating a patent on their blood thinner Lovenox into a drug testing standard, reported Bloomberg Law.
Judge Waverly D. Crenshaw Jr. gave his blessing May 29 to the agreement, which will hand $40 million to the attorneys representing the class action plaintiffs, after giving it a preliminary nod in January. The deal calls for contributions of $85 million from Sandoz and $35 million from Momenta.
It resolves an antitrust lawsuit accusing the two drugmakers of concealing their pending Lovenox patent application while lobbying the US Pharmacopeial Convention in favor of a testing protocol that would require generic makers to infringe the patent, which was later approved.
The patent covered a method for testing the quality of Lovenox’s active ingredient, used to treat and prevent clots and heart attacks.
The companies must have known what they were doing, because they had just convinced the USPC to condition the testing protocol on the withdrawal of another patent application by nonparty Sanofi-Aventis SA, the original maker of Lovenox, the suit claimed.
The scheme allegedly worked, with the agency approving a protocol that forced generic Lovenox makers to infringe the patent by performing mandated quality tests.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Geradin Partners Expands Paris Office with Key Hire
Aug 30, 2024 by
CPI
Judge Accuses Google of ‘Clear Abuse’ in Antitrust Case Over Deleted Employee Chats
Aug 29, 2024 by
CPI
Hong Kong Cleaning Company Employee Charged in Historic Antitrust Investigation Case
Aug 29, 2024 by
CPI
Inside the Yelp Suit: Allegations of Google’s Abuse of Search Power
Aug 29, 2024 by
CPI
AI Safety Bill Clears Hurdle in California, Heads to Governor’s Desk
Aug 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 22, 2024 by
CPI
CPI Talks… …With Attorney General Phil Weiser
Aug 22, 2024 by
CPI
The Bipartisan Miracle of State Antitrust Enforcement
Aug 22, 2024 by
Gwendolyn J. Lindsay Cooley
Recent Developments in State Antitrust Enforcement: Agriculture and Food Markets
Aug 22, 2024 by
Elizabeth R. Odette
State Attorneys General: Stewards of Consumer Health and Welfare
Aug 22, 2024 by
Brooke Howlett Lovrovich